Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950123-10-087744
Filing Date
2010-09-21
Accepted
2010-09-21 14:11:21
Documents
1
Period of Report
2010-10-04
Effectiveness Date
2010-09-21

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 14A c06103def14a.htm DEF 14A 233482
  Complete submission text file 0000950123-10-087744.txt   235066
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-50626 | Film No.: 101082348
SIC: 2834 Pharmaceutical Preparations